Experts Recommend Expanding HIV Prevention Medication
Individuals at high risk of contracting the virus should be offered preventive antiretroviral medications, the influential U.S. Preventive Services Task Force recommended Tuesday for the first time. The panel said at-risk people, such as those with HIV-positive sex partners and people who share needles for injecting drugs, should take a daily preexposure prophylaxis pill, known as PrEP.
How effective could this be? Researchers say the recommendation might spur more insurers to cover PrEP — which costs as much as $21,360 per year and has been shown to reduce the risk of HIV infection by up to 92 percent when taken consistently.